Riboflavin-responsive lipid myopathy and carnitine deficiency

Area of Science:

• Biochemistry
• Metabolic Disorders
• Nutritional Science

Background:

• Lipid myopathy is characterized by impaired lipid metabolism in muscle.
• Patients often present with reduced exercise capacity and intolerance to fasting.
• Carnitine deficiency can contribute to these symptoms.

Observation:

• A patient with lipid myopathy, reduced exercise capacity, and fasting intolerance was treated with riboflavin.
• Muscle and serum carnitine concentrations were initially low.
• Muscle enzyme assays revealed normal palmityl CoA dehydrogenase activity.

Findings:

• Riboflavin treatment did not alter carnitine concentrations.
• Exercise capacity doubled, and fasting tolerance improved significantly after riboflavin supplementation.
• The defect might be localized to electron transfer flavoprotein, a riboflavin derivative.

Implications:

• Riboflavin may be a potential therapeutic agent for specific types of lipid myopathy.
• This suggests a role for flavoproteins beyond simple carnitine metabolism in energy production.
• Further research is warranted to elucidate the precise mechanism of riboflavin's efficacy.